Mitoxantrone is contraindicated in patients with a known hypersensitivity to the product; for intraarterial, subcutaneous, intramuscular or intrathecal administration due to associated toxicities (see Dosage & Administration); during pregnancy and lactation (see Use in Pregnancy & Lactation).